FR UK Bienvenue "guest"  S'identifier  Rechercher :

dbCGE > Acteurs > Acteur Jean-Luc PRETET Acteurs - Rechercher

Acteur Jean-Luc PRETET

Coordonnées

Jean-Luc PRETET

Université de Franche-Comté, Laboratoire de Biologie Cellulaire / EA 3181 / IFR 133
CHU Jean Minjoz - 25030 BESANCON cedex
Tel : +33 3 81 66 91 12, e/m : jean_luc.pretet@univ-fcomte.fr

Affiliation
Equipes/Plates-formes
Aires d'expertise
Recherche:Biologie Moléculaire, Recherche:Virologie
Priorités Thématiques
C : Infections Virales et Cancer
Collègues
Equipe FC02c - Pr Christiane MOUGIN - EA3181 - Equipe Mougin
  • Ouvrir Ahmed BENZERROUK
  • Ouvrir Anne-Zélie DECRION-BARTHOD
  • Ouvrir François HERMETET
  • Ouvrir Christiane MOUGIN
Projets
Equipe FC02c - Pr Christiane MOUGIN - EA3181 - Equipe Mougin
Ouvrir2007 - PARVO-HDAC (porteur : Christiane MOUGIN)
Synergistic of combined Parvovirus and Sodium Butyrate treatments against human cervical cancer
Ouvrir2007 - REFCULTCOLUT (porteur : Patrick SANDOZ)
Utilisation de supports de culture référencés en position pour caractériser le potentiel oncogénique de corps apoptotiques de cellules dérivées de cancers du col utérin
Ouvrir2005 - CGE-DKFZ (porteur : Christine CLAVEL)
Deutsches Krebsforschungszentrum (DKFZ)/Cancéropôle du Grand-Est (CGE) joint research programme in Applied Tumour Virology HPV INFECTION AND CANCER
Equipe FC02c - Pr Christiane MOUGIN - EA3181 - Equipe Mougin
  • Ouvrir 2006 - Région Franche-Comté - (allocation doctorale, fonctionnement, équipement, déplacements pour coopération inter-sites)
  • Ouvrir 2006 - Sanofi Pasteur MSD - Distribution des génotypes d'HPV (Human PapillomaVirus) dans les condylomes en France
  • Ouvrir 2006 - Sanofi Pasteur MSD - Distribution des génotypes d'HPV (Human PapillomaVirus) dans les LGSIL en France
  • Ouvrir 2006 - Ligue contre le Cancer (Doubs) - Rôle de l'intégration de HPV16 dans l'apparition et l'évolution des lésions précancéreuses et cancéreuses du col de l'utérus
  • Ouvrir 2005 - Sanofi Pasteur MSD - Distribution des génotypes d'HPV (Human PapillomaVirus) dans les lésions de haut grade (CIN 2/3) et les cancers du col de l'utérus en France. N° de l'étude : F05-HPV-513
  • Ouvrir 2005 - BQR - Lames de microscope avec référence de position intégrée : application a l'étude de l'apoptose (collaboration IFR133, FEMTO-ST)
  • Ouvrir 2005-2007 - Région Franche-Comté - Projet en virologie tumorale appliquée (CGE-DKFZ) (allocation doctorale, fonctionnement, équipement, déplacements pour coopération inter-sites)
  • Ouvrir 2005, 2006, 2007 - Ligue du Doubs - Transfert horizontal de corps apoptotiques. Etude de l'angiogenèse dans un modèle murin de xénogreffe de cellules tumorales du col utérin
  • Ouvrir 2004 - Roche Diagnostics - Evaluation d'une méthode d'extraction d'ADN
  • Ouvrir 2004 - Roche Diagnostics - Evaluation de la trousse Amplicor HPV Test
  • Ouvrir 2004 - Ligue contre le Cancer (Doubs) - Facteurs prédictifs de l'apparition et de l'évolution des lésions précancéreuses et cancéreuses du col de l'utérus
Publications
  • Ouvrir Nardin C, Puzenat E, Pretet JL, Algros MP, Doussot A, Puyraveau M, Mougin C, Aubin F. BRAF mutation screening in melanoma: is sentinel lymph node reliable? Melanoma Res. 2015 May 21.
  • Ouvrir Riethmuller D, Jacquard AC, Lacau St Guily J, Aubin F, Carcopino X, Pradat P, Dahlab A, Pretet JL. Potential impact of a nonavalent HPV vaccine on the occurrence of HPV-related diseases in France. BMC Public Health. 2015 May 2;15:453. doi: 10.1186/s12889-015-1779-1.
  • Ouvrir Martin M, Mougin C, Pretet JL, Gil H, Meaux-Ruault N, Puzenat E, Ramanah R, Aubin F, Touze A, Coursaget P, Jacquin E, Magy-Bertrand N. Screening of human papillomavirus infection in women with systemic sclerosis. Clin Exp Rheumatol. 2014 Nov-Dec;32(6 Suppl 86):S-145-8. Epub 2014 Aug 15.
  • Ouvrir Pretet JL, Guenat D, Riethmuller D, Mougin C. New HPV16 viral biomarkers to understand the progression of cervical lesions towards cancer. Indian J Med Res. 2014 Apr;139(4):487-9. - Comment
  • Ouvrir Bellaud G, Gheit T, Pugin A, Pretet JL, Tommasino M, Mougin C, Aubin F. Prevalence of human polyomavirus DNA in eyebrow hairs plucked from patients with psoriasis treated with TNF inhibitors. J Eur Acad Dermatol Venereol. 2014 Mar 5. doi: 10.1111/jdv.12439.
  • Ouvrir Baudu A, Pretet JL, Riethmuller D, Chotard M, Mougin C, Mercier M. Prevalence and risk factors of human papillomavirus infection types 16/18/45 in a cohort of French females aged 15-23 years. J Epidemiol Glob Health. 2014 Mar;4(1):35-43. doi: 10.1016/j.jegh.2013.11.003. Epub 2014 Jan 23.
  • Ouvrir Beau-Faller M, Blons H, Domerg C, Gajda D, Richard N, Escande F, Solassol J, Denis MG, Cayre A, Nanni-Metellus I, Olschwang S, Lizard S, Piard F, Pretet JL, de Fraipont F, Bieche I, de Cremoux P, Rouquette I, Bringuier PP, Mosser J, Legrain M, Voegeli AC, Saulnier P, Morin F, Pignon JP, Zalcman G, Cadranel J. A multicenter blinded study evaluating EGFR and KRAS mutation testing methods in the clinical non-small cell lung cancer setting--IFCT/ERMETIC2 Project Part 1: Comparison of testing methods in 20 French molecular genetic National Cancer Institute platforms. J Mol Diagn. 2014 Jan;16(1):45-55. doi: 10.1016/j.jmoldx.2013.07.009. Epub 2013 Oct 30.
  • Ouvrir Beau-Faller M, Prim N, Ruppert AM, Nanni-Metellus I, Lacave R, Lacroix L, Escande F, Lizard S, Pretet JL, Rouquette I, de Cremoux P, Solassol J, de Fraipont F, Bieche I, Cayre A, Favre-Guillevin E, Tomasini P, Wislez M, Besse B, Legrain M, Voegeli AC, Baudrin L, Morin F, Zalcman G, Quoix E, Blons H, Cadranel J. Rare EGFR exon 18 and exon 20 mutations in non-small-cell lung cancer on 10 117 patients: a multicentre observational study by the French ERMETIC-IFCT network. Ann Oncol. 2014 Jan;25(1):126-31. doi: 10.1093/annonc/mdt418. Epub 2013 Nov 26.
  • Ouvrir Bellaud G, Gheit T, Pugin A, Pretet JL, Tommasino M, Mougin C, Aubin F. Prevalence of human Papillomavirus DNA in eyebrow hairs plucked from patients with psoriasis treated with TNF inhibitors. J Eur Acad Dermatol Venereol. 2014 Dec;28(12):1816-20. doi: 10.1111/jdv.12308. Epub 2013 Nov 9.
  • Ouvrir Hirchaud F, Hermetet F, Ablise M, Fauconnet S, Vuitton DA, Pretet JL, Mougin C. Isoliquiritigenin induces caspase-dependent apoptosis via downregulation of HPV16 E6 expression in cervical cancer Ca Ski cells. Planta Med. 2013 Nov;79(17):1628-35. doi: 10.1055/s-0033-1350956. Epub 2013 Nov 8.
  • Ouvrir Jacquin E, Saunier M, Mauny F, Schwarz E, Mougin C, Pretet JL. Real-time duplex PCR for simultaneous HPV 16 and HPV 18 DNA quantitation. J Virol Methods. 2013 Nov;193(2):498-502. doi: 10.1016/j.jviromet.2013.07.023. Epub 2013 Jul 24.
  • Ouvrir Jacquin E, Baraquin A, Ramanah R, Carcopino X, Morel A, Valmary-Degano S, Bravo IG, de Sanjose S, Riethmuller D, Mougin C, Pretet JL. Methylation of human papillomavirus Type 16 CpG sites at E2-binding site 1 (E2BS1), E2BS2, and the Sp1-binding site in cervical cancer samples as determined by high-resolution melting analysis-PCR. J Clin Microbiol. 2013 Oct;51(10):3207-15. doi: 10.1128/JCM.01106-13. Epub 2013 Jul 17.
  • Ouvrir Aubert M, Beytout J, Callamand P, Cheymol J, Combadiere B, Dahlab A, Denis F, Dodet B, Dommergues MA, Gagneur A, Gaillat J, Gavazzi G, Gras-le-Guen C, Haas H, Hau-Rainsard I, Malvy D, de Monleon JV, Picherot G, Pinquier D, Pretet JL, Pulcini C, Rabaud C, Regnier F, Rogeaux O, Savagner C, Soubeyrand B, Valdiguie M, Weil-Olivier C. [Update on vaccine research. Proceedings of the 15th annual conference on vaccine research organized by the National Foundation for Infectious Diseases]. Arch Pediatr. 2013 Apr;20(4):449-58. doi: 10.1016/j.arcped.2013.01.003. Epub 2013
  • Ouvrir Penso-Assathiany D, Gheit T, Pretet JL, Aubin A, Tommasino M, Mougin C, Braun R, Chosidow O, Aubin F. Presence and persistence of human papillomavirus types 1, 2, 3, 4, 27, and 57 on dermoscope before and after examination of plantar warts and after cleaning. J Am Acad Dermatol. 2013 Jan;68(1):185-6. doi: 10.1016/j.jaad.2012.07.011.
  • Ouvrir Aubin F, Gheit T, Pretet JL, Tommasino M, Mougin C. Effect of Infliximab on the UVB-Induced Apoptosis of Keratinocytes Infected by HPV38 E6/E7. ISRN Dermatol. 2013;2013:907189. doi: 10.1155/2013/907189. Epub 2013 Feb 25.
  • Ouvrir Valmary-Degano S, Jacquin E, Pretet JL, Monnien F, Girardo B, Arbez-Gindre F, Joly M, Bosset JF, Kantelip B, Mougin C. Signature patterns of human papillomavirus type 16 in invasive anal carcinoma. Hum Pathol. 2013 Jun;44(6):992-1002. doi: 10.1016/j.humpath.2012.08.019. Epub
  • Ouvrir Pretet JL, Mercier M, Riethmuller D, Aubin F, Vuitton D, Mougin C. Human papillomavirus and cardiovascular disease. J Am Coll Cardiol. 2012 Jul 3;60(1):81-2; author reply 82-3. - Comment
  • Ouvrir Gaiffe E, Pretet JL, Launay S, Jacquin E, Saunier M, Hetzel G, Oudet P, Mougin C. Apoptotic HPV positive cancer cells exhibit transforming properties. PLoS One. 2012;7(5):e36766. Epub 2012 May 4.
  • Ouvrir Emile JF, Brahimi S, Coindre JM, Bringuier PP, Monges G, Samb P, Doucet L, Hostein I, Landi B, Buisine MP, Neuville A, Bouche O, Cervera P, Pretet JL, Tisserand J, Gauthier A, Le Cesne A, Sabourin JC, Scoazec JY, Bonvalot S, Corless CL, Heinrich MC, Blay JY, Aegerter P. Frequencies of KIT and PDGFRA mutations in the MolecGIST prospective population-based study differ from those of advanced GISTs. Med Oncol. 2012 Sep;29(3):1765-72. doi: 10.1007/s12032-011-0074-y. Epub 2011 Sep
  • Ouvrir Magnin S, Viel E, Baraquin A, Valmary-Degano S, Kantelip B, Pretet JL, Mougin C, Bigand M, Girardo B, Borg C, Ferrand C. A multiplex SNaPshot assay as a rapid method for detecting KRAS and BRAF mutations in advanced colorectal cancers. J Mol Diagn. 2011 Sep;13(5):485-92. Epub 2011 Jul 8.
  • Ouvrir Galeano JAZ, Sandoz P, Gaiffe E, Launay S, Robert L, Jacquot M, Hirchaud F, Pretet JL, Mougin C. Position-referenced microscopy for live cell culture monitoring. . 2011 May 1;2(5):1307-18.
  • Ouvrir Beau-Faller M, Degeorges A, Rolland E, Mounawar M, Antoine M, Poulot V, Mauguen A, Barbu V, Coulet F, Pretet JL, Bieche I, Blons H, Boyer JC, Buisine MP, de Fraipont F, Lizard S, Olschwang S, Saulnier P, Prunier-Mirebeau D, Richard N, Danel C, Brambilla E, Chouaid C, Zalcman G, Hainaut P, Michiels S, Cadranel J. Cross-validation study for epidermal growth factor receptor and KRAS mutation detection in 74 blinded non-small cell lung carcinoma samples: a total of 5550 exons sequenced by 15 molecular French laboratories (evaluation of the EGFR mutation status for the administration of EGFR-TKIs in non-small cell lung carcinoma [ERMETIC] project--part 1). J Thorac Oncol. 2011 Jun;6(6):1006-15.
  • Ouvrir St Guily JL, Jacquard AC, Pretet JL, Haesebaert J, Beby-Defaux A, Clavel C, Agius G, Birembaut P, Okais C, Leocmach Y, Soubeyrand B, Pradat P, Riethmuller D, Mougin C, Denis F. Human papillomavirus genotype distribution in oropharynx and oral cavity cancer in France--The EDiTH VI study. J Clin Virol. 2011 Jun;51(2):100-4. Epub 2011 May 6.
  • Ouvrir St Guily JL, Clavel C, Okais C, Pretet JL, Beby-Defaux A, Agius G, Birembaut P, Jacquard AC, Leocmach Y, Soubeyrand B, Riethmuller D, Denis F, Mougin C. Human papillomavirus genotype distribution in tonsil cancers. Head Neck Oncol. 2011 Feb 7;3(1):6.
  • Ouvrir Galeano Z JA, Sandoz P, Gaiffe E, Launay S, Robert L, Jacquot M, Hirchaud F, Pretet JL, Mougin C. Position-referenced microscopy for live cell culture monitoring. Biomed Opt Express. 2011 Apr 25;2(5):1307-18.
  • Ouvrir Guerrini JS, Bouvard V, Oswald E, Alonso A, Pretet JL, Tommasino M, Mougin C, Aubin F. E6 and E7 proteins from different beta-papillomaviruses types do not interfere in UVB-induced apoptosis of HaCaT keratinocytes. Exp Dermatol. 2011 Jan;20(1):71-3. doi: 10.1111/j.1600-0625.2010.01197.x.
  • Ouvrir Ribeiro Dos Santos P, Rancez M, Pretet JL, Michel-Salzat A, Messent V, Bogdanova A, Couedel-Courteille A, Souil E, Cheynier R, Butor C. Rapid dissemination of SIV follows multisite entry after rectal inoculation. PLoS One. 2011 May 9;6(5):e19493.
  • Ouvrir Decrion-Barthod AZ, Bosset M, Plissonnier ML, Marchini A, Nicolier M, Launay S, Pretet JL, Rommelaere J, Mougin C. Sodium butyrate with UCN-01 has marked antitumour activity against cervical cancer cells. Anticancer Res. 2010 Oct;30(10):4049-61.
  • Ouvrir Pretet JL, Vidal C, Le Bail Carval K, Ramanah R, Carcopino X, Cartier I, Labouyrie E, Kantelip B, Coumes-Marquet S, Riethmuller D, Mougin C. Novaprep((R)) Vial Test is a suitable liquid-based cytology medium for high risk human papillomavirus testing by Hybrid Capture 2. J Clin Virol. 2010 Dec;49(4):286-9. Epub 2010 Sep 29.
  • Ouvrir Abramowitz L, Jacquard AC, Jaroud F, Haesebaert J, Siproudhis L, Pradat P, Aynaud O, Leocmach Y, Soubeyrand B, Dachez R, Riethmuller D, Mougin C, Pretet JL, Denis F. Human papillomavirus genotype distribution in anal cancer in France: the EDiTH V study. Int J Cancer. 2011 Jul 15;129(2):433-9. doi: 10.1002/ijc.25671. Epub 2010
  • Ouvrir Biver-Dalle C, Gheit T, Drobacheff-Thiebaut C, Vidal C, Tommasino M, Humbert P, Pretet JL, Mougin C, Aubin F. Detection of human papillomavirus DNA in plucked eyebrow hair from HIV-infected patients. J Invest Dermatol. 2010 Oct;130(10):2499-502. Epub 2010 Jun 3.
  • Ouvrir Galeano-Zea JA, Sandoz P, Gaiffe E, Pretet JL, Mougin C. PSEUDO-PERIODIC ENCRYPTION OF EXTENDED 2-D SURFACES FOR HIGH ACCURATE RECOVERY OF ANY RANDOM ZONE BY VISION Int J Optomechatronics. 2010;4(1):65-82
  • Ouvrir Aubin F, Gheit T, Pretet JL, Tommasino M, Mougin C, Chosidow O. Presence and persistence of human papillomavirus types 1, 2, and 4 on emery boards after scraping off plantar warts. J Am Acad Dermatol. 2010 Jan;62(1):151-3.
  • Ouvrir Ruer JB, Pepin L, Gheit T, Vidal C, Kantelip B, Tommasino M, Pretet JL, Mougin C, Aubin F. Detection of alpha- and beta-human papillomavirus (HPV) in cutaneous melanoma: a matched and controlled study using specific multiplex PCR combined with DNA microarray primer extension. Exp Dermatol. 2009 Oct;18(10):857-62. Epub 2009 Mar 7.
  • Ouvrir Riethmuller D, Pretet JL, Denis F, Aubin F, Pradat P, Clavel C, Dachez R, Gondry J, Carcopino X, Mougin C. [Expected impact of a quadrivalent HPV vaccine in France] J Gynecol Obstet Biol Reprod (Paris). 2009 Sep;38(5):389-95. Epub 2009 May
  • Ouvrir Nicolier M, Decrion-Barthod AZ, Launay S, Pretet JL, Mougin C. Spatiotemporal activation of caspase-dependent and -independent pathways in staurosporine-induced apoptosis of p53wt and p53mt human cervical carcinoma cells. Biol Cell. 2009 Jun 4;101(8):455-67.
  • Ouvrir Saunier M, Monnier-Benoit S, Mauny F, Dalstein V, Briolat J, Riethmuller D, Kantelip B, Schwarz E, Mougin C, Pretet JL. Analysis of human papillomavirus type 16 (HPV16) DNA load and physical state for identification of HPV16-infected women with high-grade lesions or cervical carcinoma. J Clin Microbiol. 2008 Nov;46(11):3678-85. Epub 2008 Sep 17.
  • Ouvrir Aubin F, Pretet JL, Jacquard AC, Saunier M, Carcopino X, Jaroud F, Pradat P, Soubeyrand B, Leocmach Y, Mougin C, Riethmuller D. Human papillomavirus genotype distribution in external acuminata condylomata: a Large French National Study (EDiTH IV). Clin Infect Dis. 2008 Sep 1;47(5):610-5.
  • Ouvrir Pretet JL, Jacquard AC, Saunier M, Clavel C, Dachez R, Gondry J, Pradat P, Soubeyrand B, Leocmach Y, Mougin C, Riethmuller D. Human papillomavirus genotype distribution in low-grade squamous intraepithelial lesions in France and comparison with CIN2/3 and invasive cervical cancer: the EDiTH III study. Gynecol Oncol. 2008 Aug;110(2):179-84. Epub 2008 Jun 2.
  • Ouvrir Lu XM, Monnier-Benoit S, Mo LZ, Xu SY, Pretet JL, Liu Z, Vuitton DA, Mougin C. Human papillomavirus in esophageal squamous cell carcinoma of the high-risk Kazakh ethnic group in Xinjiang, China. Eur J Surg Oncol. 2008 Jul;34(7):765-70. Epub 2007 Dec 21.
  • Ouvrir Riethmuller D, Gabelle C, Ramanah R, Sautiere JL, Pretet JL, Schaal JP, Kantelip B, Mougin C, Maillet R. [Importance of human papillomavirus (HPV) screening in the follow-up after CIN2-3 treatment] J Gynecol Obstet Biol Reprod (Paris). 2008 Jun;37(4):329-37.
  • Ouvrir Riethmuller D, Ramanah R, Pretet JL, Mougin C. [Integrating HPV testing for primary screening?] J Gynecol Obstet Biol Reprod (Paris). 2008 Feb;37 Suppl 1:S139-51. Epub - Review
  • Ouvrir Pretet JL, Jacquard AC, Carcopino X, Charlot JF, Bouhour D, Kantelip B, Soubeyrand B, Leocmach Y, Mougin C, Riethmuller D. Human papillomavirus (HPV) genotype distribution in invasive cervical cancers in France: EDITH study. Int J Cancer. 2008 Jan 15;122(2):428-32.
  • Ouvrir Pretet JL, Jacquard AC, Carcopino X, Monnier-Benoit S, Averous G, Soubeyrand B, Leocmach Y, Mougin C, Riethmuller D. Human papillomavirus genotype distribution in high grade cervical lesions (CIN 2/3) in France: EDITH study. Int J Cancer. 2008 Jan 15;122(2):424-7.
  • Ouvrir Briolat J, Dalstein V, Saunier M, Joseph K, Caudroy S, Pretet JL, Birembaut P, Clavel C. HPV prevalence, viral load and physical state of HPV-16 in cervical smears of patients with different grades of CIN. Int J Cancer. 2007 Nov 15;121(10):2198-204.
  • Ouvrir Mermet I, Guerrini JS, Cairey-Remonnay S, Drobacheff C, Faivre B, Gaillard M, Kantelip B, Pretet JL, Riethmuller D, Aubin F. Cervical intraepithelial neoplasia associated with epidermodysplasia verruciformis HPV in an HIV-infected patient: a manifestation of immune restoration syndrome Eur J Dermatol. 2007 Mar-Apr;17(2):149-52. Epub 2007 Mar 2.
  • Ouvrir Pretet JL, Charlot JF, Mougin C. Virological and carcinogenic aspects of HPV Bull Acad Natl Med. 2007 Mar;191(3):611-23; discussion 623. - Review
  • Ouvrir Aubin F, Pretet JL, Mougin C, Reithmuller D. Human papillomavirus infection Ann Dermatol Venereol. 2007 Jan;134(1):94-9. - Review
  • Ouvrir Pretet JL, Alvarez E, Monnier-Benoit S, Touze A. [Vaccination against human papillomavirus infections]. Rev Prat. 2006 Nov 15;56(17):1914-8. - Review
  • Ouvrir Monnier-Benoit S, Mauny F, Riethmuller D, Guerrini JS, Capilna M, Felix S, Seilles E, Mougin C, Pretet JL. Immunohistochemical analysis of CD4+ and CD8+ T-cell subsets in high risk human papillomavirus-associated pre-malignant and malignant lesions of the uterine cervix. Gynecol Oncol. 2006 Jul;102(1):22-31. Epub 2006 Jan 20.
  • Ouvrir Guerrini JS, Pretet JL, Mougin C, Aubin F. Human papillomavirus in melanoma. Br J Dermatol. 2006 Mar;154(3):572; author reply 573. - Comment
  • Ouvrir Pretet JL, Dalstein V, Monnier-Benoit S, Delpeut S, Mougin C. High risk HPV load estimated by Hybrid Capture II correlates with HPV16 load measured by real-time PCR in cervical smears of HPV16-infected women. J Clin Virol. 2004 Oct;31(2):140-7.
  • Ouvrir Dalstein V, Riethmuller D, Sautiere JL, Pretet JL, Kantelip B, Schaal JP, Mougin C. Detection of cervical precancer and cancer in a hospital population; benefits of testing for human papillomavirus. Eur J Cancer. 2004 May;40(8):1225-32.
  • Ouvrir Charlot JF, Pretet JL, Haughey C, Mougin C. Mitochondrial translocation of p53 and mitochondrial membrane potential (Delta Psi m) dissipation are early events in staurosporine-induced apoptosis of wild type and mutated p53 epithelial cells. Apoptosis. 2004 May;9(3):333-43.
  • Ouvrir Dalstein V, Riethmuller D, Pretet JL, Le Bail Carval K, Sautiere JL, Carbillet JP, Kantelip B, Schaal JP, Mougin C. Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study. Int J Cancer. 2003 Sep 1;106(3):396-403.
Réunions
Ouvrir
2 novembre 2011
5ème FORUM scientifique du Cancéropôle du Grand-Est
(CGE:Colloque)